Trovagene (TROV) Misses Q1 EPS by 7c

Trovagene (NASDAQ: TROV) reported Q1 EPS of ($0.36), $0.07 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $120 thousand versus the consensus estimate of $260 thousand.

For earnings history and earnings-related data on Trovagene (TROV) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Bending Spoons closes IPO, raises ~$954M on Nasdaq
• Waste stocks ride AI and healthcare boom as CLH surges 27%